Intrahepatic cholestasis of pregnancy: Biochemical predictors of adverse perinatal outcomes

Hui Chen , Yuan Zhou , Dong-rui Deng , Hai-yan Hao , Jing Dang , Jing Li

Current Medical Science ›› 2013, Vol. 33 ›› Issue (3) : 412 -417.

PDF
Current Medical Science ›› 2013, Vol. 33 ›› Issue (3) : 412 -417. DOI: 10.1007/s11596-013-1133-8
Article

Intrahepatic cholestasis of pregnancy: Biochemical predictors of adverse perinatal outcomes

Author information +
History +
PDF

Abstract

This study aimed to identify biochemical predictors of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy (ICP). A total of 106 ICP cases were analyzed retrospectively by the combination of receiver operating characteristic curve and binary logistic regression analysis. “Adverse perinatal outcomes” included spontaneous preterm labor, meconium-staining of amniotic fluid, stillbirth and Apgar score ≤7 at 1 or 5 min. Total bile acid (TBA) [AUC=0.658, 95%CI (0.536, 0.781), P=0.031] was a valuable predictor for adverse perinatal outcomes. The critical value of TBA above which adverse perinatal outcomes were observed was 40.15 μmol/L (Youden’s index=0.3). Binary multivariate logistic regression analysis revealed that the risk of adverse perinatal outcomes increased when TBA ≥40.15 μmol/L [OR=3.792, 95%CI (1.226, 11.727), P=0.021]. It is concluded that the risk of adverse perinatal outcomes in ICP increases when maternal TBA ≥40.15 μmol/L.

Keywords

cholic acids / intrahepatic cholestasis of pregnancy / pregnancy outcome

Cite this article

Download citation ▾
Hui Chen, Yuan Zhou, Dong-rui Deng, Hai-yan Hao, Jing Dang, Jing Li. Intrahepatic cholestasis of pregnancy: Biochemical predictors of adverse perinatal outcomes. Current Medical Science, 2013, 33(3): 412-417 DOI:10.1007/s11596-013-1133-8

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

KondrackieneJ, KupcinskasL. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol, 2008, 14(38): 5781-5788

[2]

KondrackieneJ, KupcinskasL. Liver diseases unique to pregnancy. Medicina (Kaunas), 2008, 44(5): 337-345

[3]

FiskNM, StoreyGNB. Fetal outcome in obstetric cholestasis. Br J Obstet Gynecol, 1988, 95(11): 1137-1143

[4]

RiosecoAJ, IvankovicMB, ManzurA, et al.. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol, 1994, 170(3): 890-895

[5]

AlsulymanOM, OuzounianJG, Ames-CastroM, et al.. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol, 1996, 175(4Pt1): 957-960

[6]

WilliamsonC, HemsLM, GoulisDG, et al.. Clinical outcome in a series of cases obstetric cholestasis identified via a patient support group. BJOG, 2004, 111(7): 676-681

[7]

WangXD, PengB, YaoQ, et al.. Perinatal outcomes of intrahepatic cholestasis of pregnancy: analysis of 1210 cases. Zhonghua Yixue Zazhi (Chinese), 2006, 86(7): 446-449

[8]

SultanaR, SarwarI, FawadA, et al.. Neonatal outcome in obstetric cholestasis patients at Ayub Teaching Hospital Abbottabad. J Ayub Med Coll Abbottabad, 2009, 21(4): 76-78

[9]

ReidR, IveyKJ, RencoretRH, et al.. Fetal complications of obstetric cholestasis. Br Med J, 1976, 1(6014): 870-872

[10]

BacqY, SapeyT, BréchotMC, et al.. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology, 1997, 26(2): 358-364

[11]

LoTK, LauWL, LamHS, et al.. Obstetric cholestasis in Hong Kong—local experience with eight consecutive cases. Hong Kong Med J, 2007, 13(5): 387-391

[12]

JohnstonWG, BaskettTF. Obstetric cholestasis. A 14 year review. Am J Obstet Gynecol, 1979, 133(3): 299-301

[13]

Al ShobailiHA, HamedHO, AI RobaeeA, et al.. Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy. Arch Gynecol Obstet, 2011, 283(6): 1219-1225

[14]

GlantzA, MarschallHU, MattssonLA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology, 2004, 40(2): 467-474

[15]

KondrackieneJ, BeuersU, ZalinkeviciusR, et al.. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol, 2007, 13(46): 6226-6230

[16]

OztekinD, AydalI, OztekinO, et al.. Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy. Arch Gynecol Obstet, 2009, 280(6): 975-979

[17]

ShawD, FrohlichJ, WittmannBA, et al.. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol, 1982, 142(6Pt1): 621-625

[18]

HeinonenS, KirkinenP. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol, 1999, 94(2): 189-193

[19]

SavoniusH, RiikonenS, GyllingH, et al.. Pregnancy outcome with intrahepatic cholestasis. Acta Obstet Gynecol Scand, 2000, 79(4): 323-325

[20]

BergB, HelmG, PetersohnL, et al.. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand, 1986, 65(2): 107-113

[21]

TurunenK, SumanenM, HaukilahtiRL, et al.. Good pregnancy outcome despite intrahepatic cholestasis. Scand J Prim Health Care, 2010, 28(2): 102-107

[22]

GeenesV, WilliamsonC. Intrahepatic cholestasis of pregnancy. World J Gastroenterol, 2009, 15(17): 2049-2066

[23]

PuslT, BeuersU. Intrahepatic cholestasis of pregnancy. Orphanet J Rare Dis, 2007, 2: 26

[24]

PathakB, SheibaniL, LeeRH. Cholestasis of pregnancy. Obstet Gynecol Clin North Am, 2010, 37(2): 269-82

[25]

LaatikainenT, TulenheimoA. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet, 1984, 22(2): 91-94

[26]

LaatikainenT, IkonenE. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol, 1977, 50: 313-318

[27]

LeeRH, KwokKM, InglesS, et al.. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol, 2008, 25(6): 341-345

[28]

SentilhesL, VerspyckE, PiaP, et al.. Fetal death in a patient with intrahepatic cholestasis of pregnancy. Obstet Gynecol, 2006, 107(2Pt2): 458-460

[29]

LeeRH, IncerpiMH, MillerDA, et al.. Sudden fetal death in intrahepatic cholestasis of pregnancy. Obstet Gynecol, 2009, 113(2Pt2): 528-531

[30]

ZeccaE, De LucaD, BarbatoG, et al.. Predicting respiratory distress syndrome in neonates from mothers with intrahepatic cholestasis of pregnancy. Early Hum Dev, 2008, 84(5): 337-341

[31]

WilliamsonC, GorelikJ, EatonBM, et al.. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clin Sci(Lond), 2001, 100(4): 363-369

[32]

GorelikJ, HardingSE, ShevchukAJ, et al.. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond), 2002, 103(2): 191-200

[33]

SepúlvedaWH, GonzálezC, CruzMA, et al.. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol, 1991, 42(3): 211-215

[34]

ZeccaE, De LucaD, MarrasM, et al.. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics, 2006, 117(5): 1669-1672

[35]

ZeccaE, De LucaD, BaroniS, et al.. Bile acid-induced lung injury in newborn infants: a bronchoalveolar lavage fluid study. Pediatrics, 2008, 121(1): 146-149

AI Summary AI Mindmap
PDF

103

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/